Overview
Community Healthcare Trust Incorporated, based in the United States, operates in the healthcare real estate sector. The company specializes in acquiring, developing, and managing healthcare properties including outpatient treatment and diagnostic facilities, urgent care centers, and small-scale, specialty hospitals. As a real estate investment trust (REIT), it focuses on investing in properties leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. Founded in 2014, Community Healthcare Trust has demonstrated a strategic emphasis on partnership with tenants providing state-of-the-art care, which in turn drives its sustained revenue generation and growth in asset portfolio. This approach allows the trust to maintain steady rental income streams while catering to the essential healthcare infrastructure needs.
Basic Stats
The share price of Community Healthcare Trust Incorporated as of September 5, 2025 is $15.66 / share. This is an increase of 1.62% from the prior week. The market cap (or net worth) of Community Healthcare Trust Incorporated as of September 5, 2025 is $421.46 MM.
The Factor Analysis chart (below right) shows a view of Community Healthcare Trust Incorporated from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 421.46 MM |
| EV | 916.67 MM |
| Shares Out. | 26.91 MM |
| Earnings Date | |
| EPS (TTM) | -0.27 |
| Dividend Yield | 12.07 % |
| Ex-Dividend Date | 2025-08-08 |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 1.40 MM |
| Short Interest | 0.93 MM |
| Short Float | 3.69 % |
| Days to Cover | 6.26 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -3.93 % |
| Volatility (1 yr) | 0.31 |
| Beta | 0.39 |
| Sharpe Ratio (1 yr) | -0.27 |
| Sortino Ratio (1 yr) | -0.45 |
| PE Ratio | -57.07 |
| Price/Book | 0.96 |
| Price/TBV | 0.96 |
| Book/Market | 1.04 |
| EBIT/EV | -0.01 |
| EBIT(3yr avg)/EV | 0.00 |
| ROA | -0.01 |
| ROE | -0.01 |
| ROIC | -0.01 |
| CROIC | 0.00 |
| OCROIC | 0.06 |
| Implied Volatility | 32.97 % |
| Put/Call OI Ratio | 4.52 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Community Healthcare Trust Incorporated is $19.48. The forecasts range from a low of $17.17 to a high of $26.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Community Healthcare Trust Incorporated. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-17 | Truist Securities | Buy | Maintains | |
| 2023-01-17 | Piper Sandler | Overweight | Maintains | |
| 2023-01-13 | Janney Montgomery Scott | Neutral | Buy | Upgrade |
| 2023-02-16 | Baird | Outperform | Maintains | |
| 2022-10-07 | Piper Sandler | Overweight | Maintains | |
| 2022-09-27 | Evercore ISI Group | Outperform | Maintains | |
| 2022-07-11 | Truist Securities | Buy | Maintains | |
| 2020-11-25 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2020-08-06 | Piper Sandler | Overweight | Maintains | |
| 2020-06-08 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2020-05-14 | Piper Sandler | Overweight | Maintains | |
| 2020-05-07 | B. Riley FBR | Buy | Neutral | Downgrade |
| 2020-04-23 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-03-20 | B. Riley FBR | Neutral | Buy | Upgrade |
| 2020-03-06 | B. Riley FBR | Neutral | Maintains | |
| 2020-02-28 | Baird | Outperform | Maintains | |
| 2019-11-18 | Sandler O'Neill | Hold | Buy | Upgrade |
| 2019-11-07 | B. Riley | Neutral | Maintains | |
| 2019-07-10 | Janney Capital | Buy | Neutral | Downgrade |
| 2019-04-23 | Berenberg | Buy | Initiate | |
| 2019-04-10 | Baird | Outperform | Initiate | |
| 2019-03-28 | DA Davidson | Neutral | Initiate | |
| 2018-11-16 | UBS | Sell | Initiate | |
| 2018-11-12 | B. Riley FBR | Neutral | Neutral | Maintains |
| 2018-08-13 | B. Riley FBR | Neutral | Neutral | Maintains |
| 2018-05-11 | B. Riley FBR | Neutral | Neutral | Maintains |
| 2017-12-19 | B. Riley FBR | Neutral | Initiate | |
| 2015-09-08 | Evercore ISI Group | Buy | Maintains | |
| 2015-06-26 | Evercore ISI Group | Buy | Initiate | |
| 2015-06-17 | Oppenheimer | Outperform | Initiate | |
| 2015-06-15 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2015-06-15 | Sandler O'Neill | Buy | Initiate | |
| 2015-06-15 | Janney Capital | Buy | Initiate | |
| 2023-11-02 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-11-02 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2023-07-06 | Colliers Securities | Neutral | Buy | Upgrade |
| 2024-05-02 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2023-11-08 | Truist Securities | Buy | Buy | Maintains |
| 2023-09-22 | Baird | Outperform | Neutral | Downgrade |
| 2024-03-22 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-05-01 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2024-04-16 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-01-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-06-17 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-16 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-08-28 | Evercore ISI Group | Underperform | Underperform | Maintains |
| 2024-08-30 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-31 | Baird | Neutral | Neutral | Maintains |
| 2024-12-18 | Truist Securities | Buy | Buy | Maintains |
| 2024-09-16 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2024-07-31 | Evercore ISI Group | In-Line | Underperform | Downgrade |
| 2024-10-31 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-09-09 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-05-23 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-08-13 | Truist Securities | Buy | Buy | Maintains |
| 2025-08-04 | Piper Sandler | Neutral | Neutral | Maintains |
